Therapeutics: Vascular endothelial growth factor receptor 3 (FLT4; VEGFR-3); vascular endothelial growth factor C (VEGF-C)

Mouse studies suggest a form of VEGF-C that selectively activates FLT4 signaling could help prevent lung graft rejection. In mice that received lung transplants, allografts undergoing acute rejection ...